Understanding nonadherence with hydroxychloroquine therapy in systemic lupus erythematosus

Journal of Rheumatology

Volumn 46, Issue 10, 2019, Pages 1309-1315

  Liu, Lucy H ^a,b   Fevrier, Helene B ^c   Goldfien, Robert ^a   Hemmerling, Anke ^d   Herrinton, Lisa J ^c  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hydroxychloroquine

Indexed keywords

AZATHIOPRINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYCHLOROQUINE; MYCOPHENOLATE MOFETIL; PREDNISONE; ANTIRHEUMATIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUCASIAN; CHARLSON COMORBIDITY INDEX; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT PREFERENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RACE DIFFERENCE; RETROSPECTIVE STUDY; SOCIAL STATUS; SYSTEMIC LUPUS ERYTHEMATOSUS; VERY ELDERLY; CALIFORNIA; HEALTH INSURANCE; MIDDLE AGED; RISK FACTOR; SOCIAL CLASS;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; CALIFORNIA; FEMALE; HUMANS; HYDROXYCHLOROQUINE; INSURANCE, PHARMACEUTICAL SERVICES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIAL CLASS;

EID: 85072784992     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.180946     Document Type: Article

References (32)

1. Koneru S, Kocharla L, Higgins GC, Ware A, Passo MH, Farhey YD, et al. Adherence to medications in systemic lupus erythematosus. J Clin Rheumatol 2008;14:195-201.
2. Feldman CH, Yazdany J, Guan H, Solomon DH, Costenbader KH. Medication nonadherence is associated with increased subsequent acute care utilization among medicaid beneficiaries with systemic lupus erythematosus. Arthritis Care Res 2015;67:1712-21.
3. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010;69:20-8.
4. World Health Organization. Adherence to long-term therapies: evidence for action. [Internet. Accessed March 28, 2019.] Available from: www.who.int/chp/knowledge/publications/adherence_report/en
5. Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care 2013;51:S11-21.
6. Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G, Le Guern V, Leroux G, Marra D, et al. Adherence to treatment in systemic lupus erythematosus patients. Best Pract Res Clin Rheumatol 2013;27:329-40.
7. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991;91:345-53.
8. Feldman CH, Collins J, Zhang Z, Subramanian SV, Solomon DH, Kawachi I, et al. Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus. Semin Arthritis Rheum 2018;48:205-13.
9. Márquez-Contreras E, López García-Ramos L, Martell-Claros N, Gil-Guillen VF, Márquez-Rivero S, Pérez-López E, et al. Validation of the electronic prescription as a method for measuring treatment adherence in hypertension. Patient Educ Couns 2018;101:1654-60.
10. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006;15:565-74.
11. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009;25:2303-10.
12. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
13. Mehat P, Atiquzzaman M, Esdaile JM, Aviña-Zubieta A, De Vera MA. Medication nonadherence in systemic lupus erythematosus: a systematic review. Arthritis Care Res 2017;69:1706-13.
14. Doshi JA, Zhu J, Lee BY, Kimmel SE, Volpp KG. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation 2009;119:390-7.
15. Tkacz J, Ellis L, Bolge SC, Meyer R, Brady BL, Ruetsch C. Utilization and adherence patterns of subcutaneously administered anti-tumor necrosis factor treatment among rheumatoid arthritis patients. Clin Ther 2014;36:737-47.
16. Scalzi LV, Hollenbeak CS, Mascuilli E, Olsen N. Improvement of medication adherence in adolescents and young adults with SLE using web-based education with and without a social media intervention, a pilot study. Pediatr Rheumatol Online J 2018;16:18.
17. Ting TV, Kudalkar D, Nelson S, Cortina S, Pendl J, Budhani S, et al. Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus. J Rheumatol 2012;39:174-9.
18. Hui Yuen JS. Usefulness of FaceTime to improve medication adherence in adolescents and young adults with systemic lupus erythematosus: a case series. Rheumatology: Current Research [Internet. Accessed March 28, 2019.] Available from: www.omicsonline.org/open-access/usefulness-of-facetime-toimprove-medication-adherence-in-adolescents-andyoung-adultswith-systemic-lupus-erythematosus-a-case-series-2161-1149-10001 53.php?aid=54701
19. Skolarus LE, Cowdery J, Dome M, Bailey S, Baek J, Byrd JB, et al. Reach out churches: a community-based participatory research pilot trial to assess the feasibility of a mobile health technology intervention to reduce blood pressure among African Americans. Health Promot Pract 2018;19:495-505.
20. Huo X, Spatz ES, Ding Q, Horak P, Zheng X, Masters C, et al. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes. BMJ Open 2017;7:e018302.
21. Chow CK, Thiagalingam A, Santo K, Kok C, Thakkar J, Stepien S, et al. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol. BMJ Open 2018;8:e019463.
22. Sarayani A, Mashayekhi M, Nosrati M, Jahangard-Rafsanjani Z, Javadi M, Saadat N, et al. Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice. Int J Clin Pharm 2018; 40:345-53.
23. Wu YP, Linder LA, Kanokvimankul P, Fowler B, Parsons BG, Macpherson CF, et al. Use of a smartphone application for prompting oral medication adherence among adolescents and young adults with cancer. Oncol Nurs Forum 2018;45:69-76.
24. Britto MT, Rohan JM, Dodds CM, Byczkowski TL. A randomized trial of user-controlled text messaging to improve asthma outcomes: a pilot study. Clin Pediatr 2017;56:1336-44.
25. Julian LJ, Yelin E, Yazdany J, Panopalis P, Trupin L, Criswell LA, et al. Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis Rheum 2009;61:240-6.
26. Tamblyn R, Eguale T, Huang A, Winslade N, Doran P. The incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort study. Ann Intern Med 2014;160:441-50.
27. Costedoat-Chalumeau N, LE Guern V, Piette JC. Routine hydroxychloroquine blood concentration measurement in systemic lupus erythematosus reaches adulthood. J Rheumatol 2015; 42:1997-9.
28. Costedoat-Chalumeau N, Houssiau F, Izmirly P, Le Guern V, Navarra S, Jolly M, et al. A prospective international study on adherence to treatment in 305 patients with flaring SLE: assessment by drug levels and self-administered questionnaires. Clin Pharmacol Ther 2018;103:1074-82.
29. Durcan L, Clarke WA, Magder LS, Petri M. Hydroxychloroquine blood levels in systemic lupus erythematosus: clarifying dosing controversies and improving adherence. J Rheumatol 2015; 42:2092-7.
30. Coleman CI, Limone B, Sobieraj DM, Lee S, Roberts MS, Kaur R, et al. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm 2012;18:527-39.
31. Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy 2014;7:35-44.
32. Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock S, Wines RC, et al. Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness). Evid Rep Technol Assess (Full Rep) 2012;1-685.